- $234.76m
- $186.75m
- $523.12m
- 93
- 92
- 39
- 87
Annual income statement for IBEX, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | R2021 June 30th | R2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | 20-F | 10-K | 10-K | 10-K |
| Standards: | IFRS | IFRS | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 368 | 405 | 443 | 493 | 523 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 108 | 150 | 181 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 362 | 386 | 426 | 472 | 483 |
| Operating Profit | 6.8 | 19.5 | 17 | 20.6 | 40.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.904 | 10.1 | 15.2 | 19.4 | 40.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.52 | 7.77 | 13.1 | 21.5 | 31.6 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 11 | 7.77 | 13.1 | 21.5 | 31.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 11 | 7.77 | 13.1 | 21.5 | 31.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.396 | 0.151 | 1.16 | 1.26 | 1.76 |
| Dividends per Share |